A Study Comparing Amounts of Tafamidis (PF-06291826) in the Blood Without Food in Healthy Volunteers
Status:
Completed
Trial end date:
2016-07-15
Target enrollment:
Participant gender:
Summary
3 different formulations and doses of tafamidis will be compared. Subjects will be fasted for
each test and every subject will test all 3 different formulations. After swallowing
tafamidis, tafamidis blood concentrations will be measured periodically for 8 days. After 14
days, subjects will take a different formulation of tafamidis and tafamidis blood
concentrations will be measured periodically for 8 days. After another 14 days, the last
formulation will be tested in the same way.